Literature DB >> 6338847

Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature.

S G Chrysant, M Dunn, D Marples, K DeMasters.   

Abstract

We saw three cases of severe reversible azotemia secondary to captopril therapy in hypertension. All patients had extensive peripheral vascular disease involving the renal arteries, and two patients (patients 2 and 3) had high levels of peripheral plasma renin activity. The azotemia occurred approximately two weeks after exposure to captopril, and fever, a maculopapular pruritic cutaneous rash, and eosinophilia developed in two patients (patients 2 and 3). The cause of the azotemia in our patients is not clearly known, since renal biopsies were not performed. The most likely cause for the azotemia was volume contraction with reduction in the glomerular filtration rate, although a direct insult to the kidney could not be excluded.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338847

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  9 in total

Review 1.  The cardiorenal syndrome: lessons from the ADHERE database and treatment options.

Authors:  J Thomas Heywood
Journal:  Heart Fail Rev       Date:  2004-07       Impact factor: 4.214

Review 2.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

3.  Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure.

Authors:  S K Mujais; F M Fouad; S C Textor; R C Tarazi; E L Bravo; N Hart; R W Gifford
Journal:  Br Heart J       Date:  1984-07

Review 4.  Drug therapy of renovascular hypertension.

Authors:  Talma Rosenthal
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

5.  Captopril: 4 years of post marketing surveillance of all patients in New Zealand.

Authors:  I R Edwards; D M Coulter; D M Beasley; D MacIntosh
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

6.  Enalapril versus triple-drug therapy in the treatment of renovascular hypertension.

Authors:  G P Reams; J H Bauer
Journal:  Drugs       Date:  1985       Impact factor: 9.546

Review 7.  Treatment of hypertension in patients with renal artery stenosis due to fibromuscular dysplasia of the renal arteries.

Authors:  Steven G Chrysant; George S Chrysant
Journal:  Cardiovasc Diagn Ther       Date:  2014-02

Review 8.  The current status of angioplasty of atherosclerotic renal artery stenosis for the treatment of hypertension.

Authors:  Steven G Chrysant
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-07-16       Impact factor: 3.738

Review 9.  Moexipril and left ventricular hypertrophy.

Authors:  George S Chrysant; P K Nguyen
Journal:  Vasc Health Risk Manag       Date:  2007
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.